Cardiac troponin i associated with the development of unrecognized myocardial infarctions detected with MRI

Clinical Chemistry

Volumn 60, Issue 10, 2014, Pages 1327-1335

  Barbier, Charlotte Ebeling ^a   Themudo, Raquel ^a   Bjerner, Tomas ^a   Johansson, Lars ^a,b   Lindahl, Bertil ^a   Venge, Per ^a   Lind, Lars ^a   Ahlström, Håkan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC TROPONIN I; GADOLINIUM PENTETATE; TROPONIN I; UNCLASSIFIED DRUG;

AGED; ASSAY; COMMUNITY LIVING; CONFERENCE PAPER; CONSENSUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; RADIOLOGIST; REFERENCE VALUE; UNRECOGNIZED MYOCARDIAL INFARCTION; BLOOD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HEART MUSCLE; INCIDENCE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

AGED; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84921819905     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.222430     Document Type: Conference Paper

References (40)

1. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
2. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113:1071-8.
3. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocar-dial infarction. JAMA 2011;306:2684-93.
4. Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, Stone GW. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial. Circ Cardiovasc Interv 2012;5:157-65.
5. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
6. Sheifer SE, Gersh BJ, Yanez ND, 3rd, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000;35:119-26.
7. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343: 1445-53.
8. Barbier CE, Bjerner T, Johansson L, Lind L, Ahl-strom H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol 2006;48: 765-71.
9. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012;308:890-6.
10. Seeger A, Fenchel M, Kramer U, Bretschneider C, Grimm F, Klumpp B, et al. Towards risk stratification in systemic atherosclerosis: value of myo-cardial function and viability imaging as an adjunct to MR angiography. Eur Radiol 2010;20: 838-45.
11. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113: 2733-43.
12. Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, et al. Prevalence and pathophysiological mechanisms of elevated cardiac tro-ponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008;29:2252-8.
13. Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of 3 different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vas-culature in Uppsala Seniors (PIVUS) study. Arte-rioscler Thromb Vasc Biol 2005;25:2368-75.
14. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 2005;184:1420-6.
15. Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG, Faraggi M. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early-and delayed-perfusion cardiac MR imaging. Radiology 2005;237:75-82.
16. Barbier CE, Nylander R, Themudo R, Ahlstrom H, Lind L, Larsson EM, et al. Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexes. J Am Coll Cardiol 2011;58:1372-7.
17. Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, et al. Age-and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 2000;10:438-42.
18. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;317:1098.
19. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
20. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012;50:871-8.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
22. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
23. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
24. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third Universal Definition of Myocardial Infarction. Circulation 2012:126;2020-35.
25. Ford WR, Menon V, Bhambhani A, Liyanage R, Khan MI, Jugdutt BI. Changes in myocardial density during postinfarction healing: effect on estimation of in vivo left ventricular mass by echo-cardiographic imaging. Can J Physiol Pharmacol 1997;75:1075-82.
26. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-9.
27. Jugdutt BI, Amy RW. Healing after myocardial infarction in the dog: changes in infarct hydroxy-proline and topography. J Am Coll Cardiol 1986; 7:91-102.
28. Christiansen JP, Edwards C, Sinclair T, Armstrong G, Scott A, Patel H, Hart H. Detection of myocar-dial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. Am J Cardiol 2006;97: 768-71.
29. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786-91.
30. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, et al. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 2010;30:1269-75.
31. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011;97:823-31.
32. Hamwi SM, Sharma AK, Weissman NJ, Goldstein SA, Apple S, Canos DA, et al. Troponin-I elevation in patients with increased left ventricular mass. Am J Cardiol 2003;92:88-90.
33. Wang L, Jerosch-Herold M, Jacobs DR, Jr., Shahar E, Folsom AR. Coronary risk factors and myocardial perfusion in asymptomatic adults: the MultiEthnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006;47:565-72.
34. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
35. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004;109:2518-23.
36. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
37. Leistner DM, Klotsche J, Pieper L, Stalla GK, Leh-nert H, Silber S, et al. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention. Clin Chem 2012;58:200-8.
38. Lindahl B, Venge P, Eggers KM, Gedeborg R, Ristiniemi N, Wittfooth S, Pettersson K. Autoan-tibodies to cardiac troponin in acute coronary syndromes. Clin Chim Acta 2010;411:1793-8.
39. Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-32.
40. Themudo RE, Lindahl B, Johansson L, Venge P, Ahlstrom H, Ebeling Barbier C, et al. Unrecognized myocardial scars detected by delayed-enhanced MRI are associated with increased levels of NT-proBNP. Coron Artery Dis 2011;22: 158-64.